Kestra Private Wealth Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
+6,421
New +$204K ﹤0.01% 1553
2023
Q3
– Sell
-6,048
Closed -$206K – 1172
2023
Q2
$206K Buy
+6,048
New +$190K 0.01% 957
2023
Q1
– Sell
-7,333
Closed -$207K – 1061
2022
Q4
$207K Sell
7,333
-2,447
-25% -$77.7K 0.01% 792
2022
Q3
$321K Sell
9,780
-4,434
-31% -$163K 0.02% 626
2022
Q2
$448K Sell
14,214
-5,636
-28% -$197K 0.03% 538
2022
Q1
$912K Sell
19,850
-1,457
-7% -$69.5K 0.05% 399
2021
Q4
$1.3M Sell
21,307
-80
-0.4% -$5.53K 0.06% 320
2021
Q3
$1.6M Buy
21,387
+9,327
+77% +$783K 0.09% 250
2021
Q2
$1.12M Buy
12,060
+420
+4% +$35.7K 0.07% 307
2021
Q1
$1.03M Buy
11,640
+5,439
+88% +$540K 0.07% 286
2020
Q4
$596K Buy
6,201
+2,354
+61% +$188K 0.04% 395
2020
Q3
$245K Buy
+3,847
New +$225K 0.02% 548

Other funds holding ARKG

Kestra Private Wealth Services's ARKG Position: Q2 2026 in Review

Kestra Private Wealth Services opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 6,421 shares worth $270K. The stake represents ﹤0.01% of the portfolio and ranks #1553 among its holdings. This is a return to the name: Kestra Private Wealth Services previously reported a position in ARKG as recently as Q2 2023.

Kestra Private Wealth Services first reported a position in ARKG in Q3 2020 and has held it in 12 quarters since. The position peaked at $1.6M in Q3 2021. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Kestra Private Wealth Services held 6,421 shares of ARK Genomic Revolution ETF worth $270K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Kestra Private Wealth Services position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1553 holding.
  • Kestra Private Wealth Services first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 12 quarters since.
  • Kestra Private Wealth Services's ARK Genomic Revolution ETF position peaked at $1.6M in Q3 2021.
  • 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.